In 2014, there were a total of 1,299 mergers and acquisitions in the health care sector – a record number, up from 1,035 the year before. That includes a recent spike in pharmaceutical transactions, including inversions, which base U.S. drug companies overseas.
A top Federal Trade Commission official, along with key experts, will meet with reporters Dec. 15 to discuss the recent surge in health care consolidation; the driving forces behind this trend; and the implications for policymakers and enforcers.
Speakers will provide the latest information about the roles of the Department of Justice and the Federal Trade Commission; efforts by policymakers; the scope and extent of consolidation among doctors, hospitals, insurers and pharmaceutical companies; and implications for consumers and other stakeholders.
-
Deborah Feinstein, director of the Federal Trade Commission’s Bureau of Competition
-
Andrea Murino, partner and co-chair of Goodwin Procter’s antitrust practice
-
George Slover, senior policy counsel at Consumers Union
-
Alan Weil of Health Affairs and Marilyn Serafini of the Alliance for Health Reform will moderate.
WHEN: Tuesday, Dec. 15, 8:15-9:30 a.m. (Breakfast available at 8 a.m.)
WHERE: National Press Club, Fourth Estate (529 14th St., NW, 13th Floor, Wash., D.C.)
RSVP: Samantha Feller sfeller@allhealth.org (202)789-2300
To register for this briefing, please contact us at info@allhealth.org or call us at (202) 789-2300.
OPEN ONLY TO MEMBERS OF THE PRESS
With thanks to the The Jayne Koskinas Ted Giovanis Foundation for Health and Policy for its support of this briefing.